Immune-Oncology Archives · BioBuzz

Loading …

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome

<img width="300" height="91" alt="" data-src="https://biobuzz.io/wp-content/uploads/2019/10/Neximmune-trans-300x91.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="91" src="https://biobuzz.io/wp-content/uploads/2019/10/Neximmune-trans-300x91.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" />

Published on : October 31, 2019September 26, 2020 Published by : Chris Frew

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables [….]

Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : September 17, 2019September 24, 2019 Published by : Steven Surdez

Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/02/GIC-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/02/GIC-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/02/GIC-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/02/GIC-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/02/GIC-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 26, 2019February 28, 2019 Published by : Steven Surdez

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region February 26, 2019 For every AstraZeneca, there are hundreds of small biotech startups and scores of life science innovators that [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 30, 2018March 15, 2019 Published by : Chris Frew

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]

New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-scaled-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2018/10/IMG_2595-scaled-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 3, 2018July 19, 2019 Published by : Gina Hagler

Immune-Oncology Symposium